The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biodegradable Embolic Microspheres Market Research Report 2024
Synopsis
Biodegradable Embolic Microspheres are indicated for use in hemostatic embolization and in embolization of arteriovenous malformations, hypervascular tumors, including uterine fibroids and meningiomas, and the prostate arteries for relief of symptoms related to Benign Prostatic Hyperplasia (BPH).
Global Biodegradable Embolic Microspheres market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biodegradable Embolic Microspheres market research.
Key manufacturers engaged in the Biodegradable Embolic Microspheres industry include Biocompatibles, Nippon Kayaku, Varian, Next Biomedical, Mermaid Medical, CeloNova BioSciences, Biosphere Medical, Promedics AG and Merit Medical Systems, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Biodegradable Embolic Microspheres were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Biodegradable Embolic Microspheres market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biodegradable Embolic Microspheres market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Biocompatibles
Nippon Kayaku
Varian
Next Biomedical
Mermaid Medical
CeloNova BioSciences
Biosphere Medical
Promedics AG
Merit Medical Systems
ABK Biomedical
BTG Corporate
Teleflex
Terumo Corporation
Tepha
Angio Dynamics
Occlugel
Jiangsu Hengrui Medicine
Segment by Type
Visualization Type
Radioactive Type
Environmentally Responsive Type
Other
Segment by Application
Hospitals And Clinics
Research Institution
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Biodegradable Embolic Microspheres report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Biodegradable Embolic Microspheres are indicated for use in hemostatic embolization and in embolization of arteriovenous malformations, hypervascular tumors, including uterine fibroids and meningiomas, and the prostate arteries for relief of symptoms related to Benign Prostatic Hyperplasia (BPH).
Global Biodegradable Embolic Microspheres market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biodegradable Embolic Microspheres market research.
Key manufacturers engaged in the Biodegradable Embolic Microspheres industry include Biocompatibles, Nippon Kayaku, Varian, Next Biomedical, Mermaid Medical, CeloNova BioSciences, Biosphere Medical, Promedics AG and Merit Medical Systems, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Biodegradable Embolic Microspheres were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Biodegradable Embolic Microspheres market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biodegradable Embolic Microspheres market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Biocompatibles
Nippon Kayaku
Varian
Next Biomedical
Mermaid Medical
CeloNova BioSciences
Biosphere Medical
Promedics AG
Merit Medical Systems
ABK Biomedical
BTG Corporate
Teleflex
Terumo Corporation
Tepha
Angio Dynamics
Occlugel
Jiangsu Hengrui Medicine
Segment by Type
Visualization Type
Radioactive Type
Environmentally Responsive Type
Other
Segment by Application
Hospitals And Clinics
Research Institution
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Biodegradable Embolic Microspheres report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Biodegradable Embolic Microspheres Market Overview
1.1 Product Overview and Scope of Biodegradable Embolic Microspheres
1.2 Biodegradable Embolic Microspheres Segment by Type
1.2.1 Global Biodegradable Embolic Microspheres Market Value Comparison by Type (2023-2029)
1.2.2 Visualization Type
1.2.3 Radioactive Type
1.2.4 Environmentally Responsive Type
1.2.5 Other
1.3 Biodegradable Embolic Microspheres Segment by Application
1.3.1 Global Biodegradable Embolic Microspheres Market Value by Application: (2023-2029)
1.3.2 Hospitals And Clinics
1.3.3 Research Institution
1.4 Global Biodegradable Embolic Microspheres Market Size Estimates and Forecasts
1.4.1 Global Biodegradable Embolic Microspheres Revenue 2018-2029
1.4.2 Global Biodegradable Embolic Microspheres Sales 2018-2029
1.4.3 Global Biodegradable Embolic Microspheres Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Biodegradable Embolic Microspheres Market Competition by Manufacturers
2.1 Global Biodegradable Embolic Microspheres Sales Market Share by Manufacturers (2018-2023)
2.2 Global Biodegradable Embolic Microspheres Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Biodegradable Embolic Microspheres Average Price by Manufacturers (2018-2023)
2.4 Global Biodegradable Embolic Microspheres Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Biodegradable Embolic Microspheres, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biodegradable Embolic Microspheres, Product Type & Application
2.7 Biodegradable Embolic Microspheres Market Competitive Situation and Trends
2.7.1 Biodegradable Embolic Microspheres Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Biodegradable Embolic Microspheres Players Market Share by Revenue
2.7.3 Global Biodegradable Embolic Microspheres Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biodegradable Embolic Microspheres Retrospective Market Scenario by Region
3.1 Global Biodegradable Embolic Microspheres Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Biodegradable Embolic Microspheres Global Biodegradable Embolic Microspheres Sales by Region: 2018-2029
3.2.1 Global Biodegradable Embolic Microspheres Sales by Region: 2018-2023
3.2.2 Global Biodegradable Embolic Microspheres Sales by Region: 2024-2029
3.3 Global Biodegradable Embolic Microspheres Global Biodegradable Embolic Microspheres Revenue by Region: 2018-2029
3.3.1 Global Biodegradable Embolic Microspheres Revenue by Region: 2018-2023
3.3.2 Global Biodegradable Embolic Microspheres Revenue by Region: 2024-2029
3.4 North America Biodegradable Embolic Microspheres Market Facts & Figures by Country
3.4.1 North America Biodegradable Embolic Microspheres Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Biodegradable Embolic Microspheres Sales by Country (2018-2029)
3.4.3 North America Biodegradable Embolic Microspheres Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biodegradable Embolic Microspheres Market Facts & Figures by Country
3.5.1 Europe Biodegradable Embolic Microspheres Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Biodegradable Embolic Microspheres Sales by Country (2018-2029)
3.5.3 Europe Biodegradable Embolic Microspheres Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biodegradable Embolic Microspheres Market Facts & Figures by Country
3.6.1 Asia Pacific Biodegradable Embolic Microspheres Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Biodegradable Embolic Microspheres Sales by Country (2018-2029)
3.6.3 Asia Pacific Biodegradable Embolic Microspheres Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Biodegradable Embolic Microspheres Market Facts & Figures by Country
3.7.1 Latin America Biodegradable Embolic Microspheres Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Biodegradable Embolic Microspheres Sales by Country (2018-2029)
3.7.3 Latin America Biodegradable Embolic Microspheres Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biodegradable Embolic Microspheres Market Facts & Figures by Country
3.8.1 Middle East and Africa Biodegradable Embolic Microspheres Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Biodegradable Embolic Microspheres Sales by Country (2018-2029)
3.8.3 Middle East and Africa Biodegradable Embolic Microspheres Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biodegradable Embolic Microspheres Sales by Type (2018-2029)
4.1.1 Global Biodegradable Embolic Microspheres Sales by Type (2018-2023)
4.1.2 Global Biodegradable Embolic Microspheres Sales by Type (2024-2029)
4.1.3 Global Biodegradable Embolic Microspheres Sales Market Share by Type (2018-2029)
4.2 Global Biodegradable Embolic Microspheres Revenue by Type (2018-2029)
4.2.1 Global Biodegradable Embolic Microspheres Revenue by Type (2018-2023)
4.2.2 Global Biodegradable Embolic Microspheres Revenue by Type (2024-2029)
4.2.3 Global Biodegradable Embolic Microspheres Revenue Market Share by Type (2018-2029)
4.3 Global Biodegradable Embolic Microspheres Price by Type (2018-2029)
5 Segment by Application
5.1 Global Biodegradable Embolic Microspheres Sales by Application (2018-2029)
5.1.1 Global Biodegradable Embolic Microspheres Sales by Application (2018-2023)
5.1.2 Global Biodegradable Embolic Microspheres Sales by Application (2024-2029)
5.1.3 Global Biodegradable Embolic Microspheres Sales Market Share by Application (2018-2029)
5.2 Global Biodegradable Embolic Microspheres Revenue by Application (2018-2029)
5.2.1 Global Biodegradable Embolic Microspheres Revenue by Application (2018-2023)
5.2.2 Global Biodegradable Embolic Microspheres Revenue by Application (2024-2029)
5.2.3 Global Biodegradable Embolic Microspheres Revenue Market Share by Application (2018-2029)
5.3 Global Biodegradable Embolic Microspheres Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Biocompatibles
6.1.1 Biocompatibles Corporation Information
6.1.2 Biocompatibles Description and Business Overview
6.1.3 Biocompatibles Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Biocompatibles Biodegradable Embolic Microspheres Product Portfolio
6.1.5 Biocompatibles Recent Developments/Updates
6.2 Nippon Kayaku
6.2.1 Nippon Kayaku Corporation Information
6.2.2 Nippon Kayaku Description and Business Overview
6.2.3 Nippon Kayaku Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Nippon Kayaku Biodegradable Embolic Microspheres Product Portfolio
6.2.5 Nippon Kayaku Recent Developments/Updates
6.3 Varian
6.3.1 Varian Corporation Information
6.3.2 Varian Description and Business Overview
6.3.3 Varian Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Varian Biodegradable Embolic Microspheres Product Portfolio
6.3.5 Varian Recent Developments/Updates
6.4 Next Biomedical
6.4.1 Next Biomedical Corporation Information
6.4.2 Next Biomedical Description and Business Overview
6.4.3 Next Biomedical Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Next Biomedical Biodegradable Embolic Microspheres Product Portfolio
6.4.5 Next Biomedical Recent Developments/Updates
6.5 Mermaid Medical
6.5.1 Mermaid Medical Corporation Information
6.5.2 Mermaid Medical Description and Business Overview
6.5.3 Mermaid Medical Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mermaid Medical Biodegradable Embolic Microspheres Product Portfolio
6.5.5 Mermaid Medical Recent Developments/Updates
6.6 CeloNova BioSciences
6.6.1 CeloNova BioSciences Corporation Information
6.6.2 CeloNova BioSciences Description and Business Overview
6.6.3 CeloNova BioSciences Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.6.4 CeloNova BioSciences Biodegradable Embolic Microspheres Product Portfolio
6.6.5 CeloNova BioSciences Recent Developments/Updates
6.7 Biosphere Medical
6.6.1 Biosphere Medical Corporation Information
6.6.2 Biosphere Medical Description and Business Overview
6.6.3 Biosphere Medical Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biosphere Medical Biodegradable Embolic Microspheres Product Portfolio
6.7.5 Biosphere Medical Recent Developments/Updates
6.8 Promedics AG
6.8.1 Promedics AG Corporation Information
6.8.2 Promedics AG Description and Business Overview
6.8.3 Promedics AG Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Promedics AG Biodegradable Embolic Microspheres Product Portfolio
6.8.5 Promedics AG Recent Developments/Updates
6.9 Merit Medical Systems
6.9.1 Merit Medical Systems Corporation Information
6.9.2 Merit Medical Systems Description and Business Overview
6.9.3 Merit Medical Systems Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Merit Medical Systems Biodegradable Embolic Microspheres Product Portfolio
6.9.5 Merit Medical Systems Recent Developments/Updates
6.10 ABK Biomedical
6.10.1 ABK Biomedical Corporation Information
6.10.2 ABK Biomedical Description and Business Overview
6.10.3 ABK Biomedical Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.10.4 ABK Biomedical Biodegradable Embolic Microspheres Product Portfolio
6.10.5 ABK Biomedical Recent Developments/Updates
6.11 BTG Corporate
6.11.1 BTG Corporate Corporation Information
6.11.2 BTG Corporate Biodegradable Embolic Microspheres Description and Business Overview
6.11.3 BTG Corporate Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.11.4 BTG Corporate Biodegradable Embolic Microspheres Product Portfolio
6.11.5 BTG Corporate Recent Developments/Updates
6.12 Teleflex
6.12.1 Teleflex Corporation Information
6.12.2 Teleflex Biodegradable Embolic Microspheres Description and Business Overview
6.12.3 Teleflex Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Teleflex Biodegradable Embolic Microspheres Product Portfolio
6.12.5 Teleflex Recent Developments/Updates
6.13 Terumo Corporation
6.13.1 Terumo Corporation Corporation Information
6.13.2 Terumo Corporation Biodegradable Embolic Microspheres Description and Business Overview
6.13.3 Terumo Corporation Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Terumo Corporation Biodegradable Embolic Microspheres Product Portfolio
6.13.5 Terumo Corporation Recent Developments/Updates
6.14 Tepha
6.14.1 Tepha Corporation Information
6.14.2 Tepha Biodegradable Embolic Microspheres Description and Business Overview
6.14.3 Tepha Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Tepha Biodegradable Embolic Microspheres Product Portfolio
6.14.5 Tepha Recent Developments/Updates
6.15 Angio Dynamics
6.15.1 Angio Dynamics Corporation Information
6.15.2 Angio Dynamics Biodegradable Embolic Microspheres Description and Business Overview
6.15.3 Angio Dynamics Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Angio Dynamics Biodegradable Embolic Microspheres Product Portfolio
6.15.5 Angio Dynamics Recent Developments/Updates
6.16 Occlugel
6.16.1 Occlugel Corporation Information
6.16.2 Occlugel Biodegradable Embolic Microspheres Description and Business Overview
6.16.3 Occlugel Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Occlugel Biodegradable Embolic Microspheres Product Portfolio
6.16.5 Occlugel Recent Developments/Updates
6.17 Jiangsu Hengrui Medicine
6.17.1 Jiangsu Hengrui Medicine Corporation Information
6.17.2 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Description and Business Overview
6.17.3 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Product Portfolio
6.17.5 Jiangsu Hengrui Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biodegradable Embolic Microspheres Industry Chain Analysis
7.2 Biodegradable Embolic Microspheres Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biodegradable Embolic Microspheres Production Mode & Process
7.4 Biodegradable Embolic Microspheres Sales and Marketing
7.4.1 Biodegradable Embolic Microspheres Sales Channels
7.4.2 Biodegradable Embolic Microspheres Distributors
7.5 Biodegradable Embolic Microspheres Customers
8 Biodegradable Embolic Microspheres Market Dynamics
8.1 Biodegradable Embolic Microspheres Industry Trends
8.2 Biodegradable Embolic Microspheres Market Drivers
8.3 Biodegradable Embolic Microspheres Market Challenges
8.4 Biodegradable Embolic Microspheres Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
